Vora says quantitative research is the future and the company will work towards taking a lead in quant-based asset and wealth management services
Just as periodic health checks ensure our physical wellbeing, a review with your investment advisor at periodic intervals (say, every 3-6 months) can keep your portfolio robust and in line with your financial goals.
CNBC-TV18 in a special show called ‘Get Rich’ asked market experts Arun Thukral, MD & CEO, Axis Securities and Amisha Vora, Joint MD, Prabhudas Lilladher Group to share their views on how to further your gains
Amisha Vora, Joint Managing Director, Prabhudas Lilladher says markets are showing good amount of resilience. This resilience and inflows could continue, so its still a buy on decline market.
Amisha Vora, Joint Managing Director at Prabhudas Lilladher recommends to reamin invested in Bharat Financial Inclusion.
Amisha Vora, Joint Managing Director at Prabhudas Lilladher recommends staying with ITC.
Speaking to CNBC-TV18 Amisha Vora of Prabhudas Lilladher said that demonetisation will lead to downward revision in one or two quarters at least. The critical question is whether global funds will overlook the pain for two quarters?
Dilip Bhat says that a combination of recent reforms like the Mauritius Treaty, P-Note amendment and a possible US Fed rate hike in June have been overwhelming for the market in the short term.
According to Amisha Vora, Joint Managing Director, Prabhudas Lilladher largecaps would make good investments for women and recommends ICICI Bank among them and Jubilant Life from the midcap space
Amisha Vora of Prabhudas Lilladher is of the view that one may prefer ICICI Bank, UltraTech Cement and L&T Finance.
According to Amisha Vora of Prabhudas Lilladher the largecaps currently seemed to be poised interestingly and so would be a good time to start looking at them.
Amisha Vora of Prabhudas Lilladher is of the view that ICICI Bank and State Bank of India look attractive.
Vora is bullish on the transmission & distribution (T&D) business and rates KEC International among her top picks in this segment.
Amisha Vora of Prabhudas Lilladher says earnings need time to catch up and there has been no short-term booster dose that has come from the government through the Budget. Hence India continues to remain vulnerable to each global event
Amisha Vora of Prabhudas Lilladher is of the view that one may prefer ICICI Bank and Federal Bank.
According to Amisha Vora of Prabhudas Lilladher, one may prefer KPIT Technologies and Ashoka Buildcom.
Sudarshan Sukhani of s2analytics sees 8,100 as a benchmark for the market and advises against buying below those levels.
According to Amisha Vora, Joint Managing Director at Prabhudas Lilladher, one may accumulate Tata Consultancy Services.
Amisha Vora, Joint Managing Director at Prabhudas Lilladher is of the view that one may accumulate Federal Bank on declines.
She expects more trading sessions filled with volatility but it is still a good time to buy, backed by improving macros, given the trader has the appetite to face more volatility.
Amisha Vora Joint Managing Director Prabhudas Lilladher, Neeraj Deewan Director Quantum Securities and Siddharth Bhamre of Angel Broking in an interview to CNBC-TV18 share their readings and outlook on stocks and market going forward.
In an interview to CNBC-TV18's, Amisha Vora, Joint Managing Director at Prabhudas Lilladher and Neeraj Deewan, Director at Quantum Securities debate on given the rally in the PSU banks, is it the time to exit PSU banks or would you stay invested?
According to Amisha Vora, Joint MD of Prabhudas Lilladher, Hero Motocorp, ACC, Apollo Tyres and Wipro are the top picks.
Amisha Vora, Joint Md at Prabhudas Lilladher is of the view that Aurobindo Pharma may test Rs 625-650. "Over a medium to long-term I feel the appreciation of 25-30 percent per annum is still possible," he adds.
Stock specific, Amisha Vora thinks Aurobindo Pharma could appreciate about 25-30 percent. The house has a target price of Rs 625-650.